1. Introduction {#sec1-marinedrugs-15-00281}
===============

Flatworms are invertebrates that belong to Platyhelminthes. About 4500 species of flatworms have been reported, of which over 1000 species are exclusively marine flatworms primarily belonging to *Turbellaria* polyclad \[[@B1-marinedrugs-15-00281]\]. Marine flatworms are 3--20 cm in length but some are quite small. Most marine flatworms are free-living organisms and they are found to hide under rocks or inside empty shells in the daytime. In recent years, flatworms have attracted broad research interests worldwide. Several studies on the reproductive system of flatworms provided useful information for research on stem cells \[[@B2-marinedrugs-15-00281]\], ageing \[[@B3-marinedrugs-15-00281]\] and bioadhesion \[[@B4-marinedrugs-15-00281]\]. Recent reports showed that flatworms are suitable models for probing environmental changes, such as salinity stress \[[@B5-marinedrugs-15-00281]\] and oxygen concentrations variations \[[@B6-marinedrugs-15-00281]\].

Chemical defense is popular among marine invertebrates \[[@B7-marinedrugs-15-00281]\], such as sponges, corals and sea hares. In many cases, chemical weapons are produced by microorganisms associated with their invertebrate hosts \[[@B8-marinedrugs-15-00281],[@B9-marinedrugs-15-00281],[@B10-marinedrugs-15-00281]\]. Marine flatworms may also adopt chemical defense to protect themselves. Indeed, the deadly toxin tetrodotoxin (TTX) has been detected in marine flatworm *Planocera* sp. \[[@B11-marinedrugs-15-00281]\] and further investigation of *Planocera multitentaculata* indicated that a high concentration of TTX existed in the genitalia, digestive organs and other tissues \[[@B12-marinedrugs-15-00281]\]. There is doubt that TTX and its analogs might be produced by the endogenous/symbiotic bacteria of these flatworms \[[@B13-marinedrugs-15-00281]\]. Unfortunately, only a handful studies \[[@B14-marinedrugs-15-00281],[@B15-marinedrugs-15-00281],[@B16-marinedrugs-15-00281],[@B17-marinedrugs-15-00281]\] have been carried out to investigate the microorganisms associated with flatworms. Gruber-Vodicka et al. \[[@B14-marinedrugs-15-00281]\] discovered the symbiotic relationship between *Paracatenula galateia* and an uncultured sulfur-oxidizing *Alphaproteobacteria* strain. Xu et al. \[[@B15-marinedrugs-15-00281]\], Zhang et al. \[[@B16-marinedrugs-15-00281]\] and Lin et al. \[[@B17-marinedrugs-15-00281]\] described the identification of new bacteria species isolated from a marine flatworm *Paraplanocera* sp. Since Acoelomorpha flatworms had been excluded from Platyhelminthes to be an independent phylum \[[@B18-marinedrugs-15-00281]\], the symbiotic relationship and chemical defense between algae and Acoelomorpha flatworms will not be discussed in this study. Therefore, it will be of interest to investigate the bacteria associated with marine flatworms, which may provide more clues to understand their chemical defensive system. Geldanamycin (GM), firstly reported by Deboer et al. \[[@B19-marinedrugs-15-00281]\], was discovered from *Streptomyces hygroscopicus.* This compound belongs to the benzoquinone ansamycin family possessing a 19-membered macrocyclic lactam. The biosynthesis of GM and its analogs requires polyketide synthase (PKS) genes. GM is an antibiotic with potent anticancer, antibacterial, anti-protozoa and antifungal activities. However, its hepatotoxicity and poor water solubility limit the therapeutic efficiency of GM. Therefore, studies on GM analogs have now gained increasing attention. Accordingly, various GM analogs have been developed by chemical modification and by engineered biosynthesis \[[@B20-marinedrugs-15-00281]\]. Especially, GM and its two semi-synthetic analogs 17-allylaminogeldanamycin (17-AAG) and 17-dimethylaminoethylamino-17-demethoxygeldanamyein (17-DMAG) show a broad spectrum of anticancer activity by inhibiting Hsp90 (Heat shock protein 90) activity \[[@B21-marinedrugs-15-00281],[@B22-marinedrugs-15-00281]\]. Although both 17-AAG and 17-DMAG were used in clinical trials, they failed in phase II and I clinical trials, due to their severe hepatotoxicity, low aqueous solubility and limited oral bioavailability \[[@B23-marinedrugs-15-00281]\]. By now, only a few of natural GM analogs have been discovered from *Streptomyces hygroscopicus* and other *Streptomyces* sp. \[[@B24-marinedrugs-15-00281],[@B25-marinedrugs-15-00281],[@B26-marinedrugs-15-00281]\]. Hence, discovering natural and potent geldanamycins (GMs) with excellent bioactivities without causing the above common problems will be meaningful for the development of anticancer candidates.

In this study, we isolated and identified the bacteria from a marine flatworm *Paraplanocera* sp., conducted bioactive (activity against Methicillin-Resistant *Staphylococcus aureus* (MRSA) ATCC43300 and cytotoxic effects on HeLa cells) and chemical (ultra-performance liquid chromatography--mass spectrometry (UPLC-MS)) diversity screening with the ethyl acetate (EA) crude extracts of the cultured bacteria, and performed further isolation, structure elucidation, and bioactive evaluation for the obtained metabolites of the target strains. One novel GM analog 4,5-dihydro-17-*O*-demethylgeldanamycin (**1**) and three known GMs (**2**--**4**) were isolated from the fermentation broth of XY-FW47 (see [Figure 1](#marinedrugs-15-00281-f001){ref-type="fig"}). All of these compounds were tested for anti-MRSA ATCC43300, cytotoxic, and antifungal activities, and their structure--activity relationship (SAR) was also preliminarily discussed. This is the first report on studying biodiversity and chemical diversity of bacteria associated with marine flatworms, which calls more attention to exploit the biological and chemical potential of marine flatworms.

2. Results and Discussion {#sec2-marinedrugs-15-00281}
=========================

2.1. Sample Identification {#sec2dot1-marinedrugs-15-00281}
--------------------------

A marine flatworm ([Figure 2](#marinedrugs-15-00281-f002){ref-type="fig"}), collected at depth between 1 and 3 m in the intertidal zone of Yung Shue O, Hong Kong (114°21′ E, 22°24′ N) in January 2014, was originally identified as *Stylochus* sp. by a simple morphological comparison, but was later identified to be *Paraplanocera* sp. based on its 18S rRNA gene sequence (1260 bp). Maximum likelihood tree ([Figure 3](#marinedrugs-15-00281-f003){ref-type="fig"}) shows the phylogenetic position of the *Paraplanocera* sp. which is affiliated to the superfamily of Stylochoidea and forms the closest genetic distance with *Paraplanocera oligoglena*. The GenBank accession number for the 18S rRNA gene sequence of *Paraplanocera* sp. is MF319765.

2.2. Isolation and Taxonomy of Bacteria from the Marine Flatworm Paraplanocera *sp.* {#sec2dot2-marinedrugs-15-00281}
------------------------------------------------------------------------------------

A total of 141 strains of bacteria associated with the marine flatworm *Paraplanocera* sp. were isolated and identified, including 37 species of actinobacteria belonging to nine genera and 64 species of non-actinobacteria affiliating to 27 genera (the information of the isolates are detailed in [Table 1](#marinedrugs-15-00281-t001){ref-type="table"}). The 16S rRNA genes of all the cultured isolates have high similarity (98.5--100%) with their reference strains except the three novel species (marked in bold in [Table 1](#marinedrugs-15-00281-t001){ref-type="table"}). There were 45 strains of actinomycetes listed as follows, *Streptomyces* (14 strains of 13 species), *Micromonospora* (12 strains of eight species), *Mycobacterium* (nine strains of eight species), *Tsukamurella* (two strains of two species), *Microbacterium* (two strains of two species), *Micrococcus* (two strains of one species), *Pseudonocardia* (two strains of one species), *Brevibacterium* and *Arthrobacter*. There were 96 strains of non-actinomycetes, including *Bacillus* (33 strains of 22 species), *Vibrio* (11 strains of six species), *Halobacillus* (six strains of five species), *Microbulbifer* (four strains of three species), *Ruegeria* (11 strains of two species), *Pseudovibrio* (five strains of three species), *Fictibacillus* (two strains of two species), *Pseudoalteromonas* (two strains of one species), *Photobacterium*, *Joostella* (two strains of one species), *Flammeovirga* (two strains of one species), *Arcobacter*, *Staphylococcus*, *Aquimarina*, *Tenacibaculum*, *Roseovarius*, *Cupriavidus*, *Oceanobacillus*, *Deinococcus*, *Pseudomonas*, *Paenibacillus*, *Stenotrophomonas*, *Paracoccus*, *Psychrobacillus*, *Alcaligenes* (two strains of two species), *Roseivirga* and *Methylobacterium*. These results showed a great diversity of culturable bacteria associated with marine flatworm *Paraplanocera* sp.

Three novel bacterial strains were discovered from this study. Two strains, UST20140214-052 and UST20140214-015B, had been characterized to be new species of the genus *Pseudovibrio* and published elsewhere \[[@B15-marinedrugs-15-00281],[@B16-marinedrugs-15-00281]\]. In these years, there is a growing interest in *Pseudovibrio* species as more and more isolates have been identified from sponges, corals, and sea squirts and, among them, some strains have genomic interactions with host marine invertebrates and gene clusters for producing secondary metabolites to protect the host from pathogens \[[@B27-marinedrugs-15-00281]\]. Another new species strain, XY-FW106, was characterized to be *Deinococcus planocerae* \[[@B17-marinedrugs-15-00281]\]. Interestingly, XY-FW106 showed resistance against ultraviolet irradiation \[[@B28-marinedrugs-15-00281]\], which might provide some protective function for the survival of the host flatworm, which lived in the shallow waters.

2.3. The Bioactive and UPLC-MS Chemical Screening of the Isolated Bacteria {#sec2dot3-marinedrugs-15-00281}
--------------------------------------------------------------------------

All 141 bacterial isolates were fermented on a small scale and the EA crude extracts of their bacterial fermentation broth were evaluated for anti-MRSA (strain ATCC43300) and cytotoxic (HeLa cells) activities. In total, eight extracts showed anti-MRSA activity and seven showed cytotoxic activity. Among them, extracts of strains XY-FW47 and XY-FW120 showed both potent antibacterial and cytotoxic activities. Four strains of *Streptomyces* showed the strongest anti-MRSA activity. In addition, one *Arthrobacter soli* strain and one *Bacillus siamensis* strain showed moderate activity against MRSA, and the latter strain also showed weak effects on HeLa cells ([Table 2](#marinedrugs-15-00281-t002){ref-type="table"} and [Table 3](#marinedrugs-15-00281-t003){ref-type="table"}). Two strains of *Streptomyces* revealed high activity against HeLa cells, while two other *Streptomyces* strains and one *Paracoccus* strain showed moderate activity against HeLa cells ([Table 3](#marinedrugs-15-00281-t003){ref-type="table"}). These results suggested that the bacteria associated with the marine flatworms might be a rich source of bioactive compounds. In this study, the strains of XY-FW47 and XY-FW120 were selected as the target strains for further chemical characterization due to their strongest bioactivities.

Further chemical analyses on the two strains of *Streptomyces* (XY-FW120 and XY-FW47) were proceeded by UPLC-MS on a reversed phase C18 column with a gradient solution ACN/H~2~O (5--95%, 25 min). As shown in [Figure 4](#marinedrugs-15-00281-f004){ref-type="fig"}, XY-FW120 produced a main metabolite with a characteristic ultraviolet (UV) absorption of 430--440 nm and a high resolution electrospray ionization mass spectroscopy (HR-ESI-MS) \[M + H\]^+^ of 1255.6924. Combined database searching (Dictionary of natural products, SciFinder, AntiBase, MarinLit, etc.) with extensive literature searching suggested this metabolite was very likely to be actinomycin D (see [Figure 4](#marinedrugs-15-00281-f004){ref-type="fig"} and [Figure S9](#app1-marinedrugs-15-00281){ref-type="app"}) which had already been described by Meienhofer and Atherton \[[@B29-marinedrugs-15-00281]\]. As actinomycin D is a well-known antibiotic with antitumor activity, this also explains why the extract of XY-FW120 showed strong activity in both bioassays. It was also reported that the same species *Streptomyces parvulus* DAUFPE 3124 produced only actinomycin D \[[@B30-marinedrugs-15-00281]\]. However, the strain XY-FW120 produced not only a high level of actinomycin D, but also a few known actinomycin D analogs with trace amounts (data not shown). As the UV absorption patterns as well as the high resolution mass data of these actinomycin compounds were the same as those described in the literature, there is a very high chance that these compounds are exactly the same as those reported. However, there might be one case that our consumption could be wrong: enantiomers are also possible, although the odds are low. Based on these analyses, the metabolites of strain XY-FW120 are almost fully understood, thus we did not proceed for further investigation on this strain to characterize its metabolites.

HPLC analysis of the metabolites of XY-FW47, which was closely related to *Streptomyces samsunensis* M1463^T^ \[[@B31-marinedrugs-15-00281]\], indicated a series of compounds with very similar UV absorption patterns. All of these compounds all had characteristic UV absorption at 305 nm with their HR-ESI-MS \[M − H\]^−^ ranging from 533.2987 to 561.2936 (see [Figure 5](#marinedrugs-15-00281-f005){ref-type="fig"}). Combined database searching with extensive literature searching based on these spectroscopic data, led us to conclude that these compounds with HR-ESI-MS \[M − H\]^−^ 559.2778, 545.2548 and 561.2936 were GM, 17-*O*-demethylgeldanamycin and 4,5-dihydrogeldanamycin, respectively \[[@B19-marinedrugs-15-00281],[@B32-marinedrugs-15-00281],[@B33-marinedrugs-15-00281]\]. GM, previously isolated from *Streptomyces hygroscopicus*, is a benzoquinone antibiotic containing the typical structures of benzoquinone and dienamide. This class of compounds showed various bioactivities, including anticancer, anti-protozoa, antimalarial and antifungal activities \[[@B34-marinedrugs-15-00281],[@B35-marinedrugs-15-00281]\]. Based on extensive investigation of the literatures and the analyses of UPLC-MS data, it is concluded that these compounds with HR-ESI-MS \[M − H\]^−^ 547.2805 (retention time at 8.0 min), 533.2992 and 547.2636 (retention time at 12.0 min) are very likely novel GMs produced by the strain XY-FW47 (see [Figure S10](#app1-marinedrugs-15-00281){ref-type="app"}). As new analogs may provide more selectivity or low toxicity, it is worth isolating these potential new GMs. Consequently, this bacterial strain was chosen to be the target strain for further study. The 16S rRNA gene sequence of strain XY-FW47 was deposited in GenBank with the accession number MF664376.

2.4. Structural Elucidation of the Isolated Compounds {#sec2dot4-marinedrugs-15-00281}
-----------------------------------------------------

In total, four compounds were isolated and identified from strain XY-FW47. Compound **1** was isolated as a yellow amorphous powder. The molecular formula of Compound **1** was established as C~28~H~40~N~2~O~9~ by HR-ESI-MS (*m*/*z* 547.2636, \[M − H\]^−^), with 10 degrees of unsaturation. The ^13^C and DEPT NMR spectra showed 28 carbon signals ([Table 4](#marinedrugs-15-00281-t004){ref-type="table"}), which were assigned with the assistance of the distortionless enhancement by polarization transfer (DEPT) spectrum to six methyls, four methylenes, seven methines, and nine quaternary carbons. The signals of ^1^H-NMR spectra also revealed six methyl groups (*δ*~H~ 3.41, 3.35, 1.91, 1.68, 0.98, and 0.96) and four methines.

The gross structure of Compound **1** and all of the ^1^H and ^13^C NMR data associated with the molecule were determined by 2D NMR studies, including ^1^H-^1^H COSY, HSQC and HMBC experiments. The key ^1^H-^1^H COSY correlations of H-3/H~2~-4/H~2~-5/H-6/H-7, H-9/H-10/H-11/H-12/H~2~-13/H-14/H~2~-15, H-10/CH~3~-26 and H-14/CH~3~-28, together with the HMBC correlations from CH~3~-22 to C-1/C-2/C-3, from OCH~3~-23 to C-6, from H-7 to C-8/C-9/C-24, from CH~3~-25 to C-8/C-9 and from CH~3~-27 to C-12, indicated the existence of the ansa ring (see [Figure 6](#marinedrugs-15-00281-f006){ref-type="fig"}), which was similar to 17-*O*-demethylgeldanamycin \[[@B32-marinedrugs-15-00281]\]. Comparing with the 1D and 2D NMR signals of 17-*O*-demethylgeldanamycin, the lost of the double bond at C-4 and C-5 in Compound **1**, which was replaced by two methenes. The NOSY correlations of H-6/H-7/H-12, and H-10/H-11/H-14 indicated the absolute configuration of Compound **1** that was also consistent with 17-*O*-demethylgeldanamycin. Thus, the structure of Compound **1** was identified.

The structures of Compounds **2**--**4** were identified as 17-*O*-demethylgeldanamycin, geldanamycin and 4,5-dihydrogeldanamycin, respectively, by the NMR and UPLC-MS data, and comparing their spectroscopic data with those data reported by Hong et al. and Ni et al. \[[@B36-marinedrugs-15-00281],[@B37-marinedrugs-15-00281]\].

2.5. Bioactive Evaluation and Structure--Activity Relationship {#sec2dot5-marinedrugs-15-00281}
--------------------------------------------------------------

The bioactivities (anti-MRSA, anti-HeLa Cell and antifungal) of Compounds **1**--**4** were evaluated. These compounds showed no activity against MRSA. Compound **3** GM exhibited potent activity against HeLa cells with EC~50~ 1.12 μg/mL. It also showed antifungal activity against the plant pathogen *Setosphaeria turcica* with MIC 2.40 μg/mL. Previous cytotoxic tests (FRE/*erbB-2* tumors) of 4,5-dihydrogeldanamycin (**4**) revealed much weaker activity than GM (IC~50~ = 230 and 70 nM, respectively) \[[@B38-marinedrugs-15-00281]\]. Compounds 17-*O*-demethylgeldanamycin (**2**) and 17-*O*-demethylgeldanamycin hydroquinone showed much more cytotoxicity towards normal P19-derived neurons than GM at 1 nM \[[@B39-marinedrugs-15-00281]\]. These data together with the present results of Compound **1**--**4** indicate that the double bond at C-4,5 and the methoxy group at C-17 position are essential for increasing anti-HeLa cells and anti-*S. turcica* activities of GMs. As none of the GMs were active against MRSA, the potent anti-MRSA activity of the crude XY-FW47 extract might be contributed by the trace GMs or other types of metabolites which we were not able to isolate. We will need to optimize fermentation conditions of XY-FW47 to obtain enough quantities of these compounds in the future studies.

3. Materials and Methods {#sec3-marinedrugs-15-00281}
========================

3.1. Bacteria Isolation and Identification {#sec3dot1-marinedrugs-15-00281}
------------------------------------------

A marine flatworm was collected at depth between 1 and 3 m intertidal zone of Yung Shue O, Hong Kong (114°21′ E, 22°24′ N) in January 2014, and identified as *Paraplanocera* sp. based on 18S rRNA gene sequencing (1260 bp). The bacterial isolation method was in accordance with the method described by Xu et al. \[[@B15-marinedrugs-15-00281]\] using modified BD Difco^TM^ R2A agar (adding 17 g/L seasalt). The 16S rRNA gene sequence of the isolations were determined by PCR using universal primers 27F and 1492R, then the isolates were identified by the blast program in the NCBI database.

3.2. Bacteria Fermentation {#sec3dot2-marinedrugs-15-00281}
--------------------------

Small scale fermentation of the cultured bacteria was carried out as follows: seed cultures of the strain were collected in 50 mL Falcon centrifuge tubes, with each containing 15 mL of SGTYP medium with sea salts (5.0 g soluble starch, 5.0 g glucose, 1.0 g tryptone, 1.0 g yeast extract, 1.0 g peptone, 17.0 g sea salts per litre, pH 7.6 ± 0.2). Then fresh inoculum was inoculated in 250 mL flasks with each containing 80 mL of SGTYP medium with sea salts (5.0 g soluble starch, 5.0 g glucose, 1.0 g tryptone, 1.0 g yeast extract, 1.0 g peptone, 17.0 g sea salts per litre, pH 7.6 ± 0.2). The flasks were incubated at 28 °C for 5 days before harvesting. The fermentation broth was extracted with ethyl acetate (EA) three times of the total volume (1:3 *v*/*v*). The EA crude extract of the bacterial fermentation broth was obtained and prepared as 50 mg/mL stock solution in DMSO for testing.

3.3. Bioactive and Chemical Screening {#sec3dot3-marinedrugs-15-00281}
-------------------------------------

The pathogen MRSA ATCC43300 was incubated in LB broth (10 g tryptone, 5 g yeast extract and 10 g NaCl per liter) at 28 °C for 12 h and then diluted 5000 times with fresh LB broth. The tested samples (2 μL) were added to each well of 24-well plates with 1 mL of the diluted pathogen solution. The pathogen was then incubated at 28 °C and the optical density at 600 nm was measured 24 h after inoculation with vancomycin (50 μg/mL) as positive controls. The cytotoxic assays were performed using the method described by Li et al. \[[@B40-marinedrugs-15-00281]\]. HeLa cells were inoculated and incubated in 24-well plates for 12 h before adding the tested samples. After incubation for 48 h, the CCK method was used to assay the cell viability. Three biological replicates were carried out for each sample and each bioassay experiment was repeated three times.

The ESI-TOF and mass spectra of the isolates were acquired from a UPLC-TOF-MS system (ultra-performance liquid chromatography--time of fly-mass spectrometry) using a Bruker microTOF-q II (Bruker Daltonics GmbH, Bremen, Germany) mass spectrometer coupled to a Waters ACQUITY UPLC system (Waters, London, UK).

3.4. Extraction and Compounds Isolation {#sec3dot4-marinedrugs-15-00281}
---------------------------------------

Large scale fermentation (50 L) and the extraction of XY-FW47 were obtained as the described method of small scale. The EA crude extract of XY-FW47 was separated by reverse phase C18 chromatography with water and methanol solvent mixtures of H~2~O--MeOH (7:3), H~2~O--MeOH (5:5), H~2~O--MeOH (3:7), H~2~O--MeOH (1:9), and 100% MeOH. The fractions of H~2~O--MeOH (3:7, *v*/*v*) was evaporated and labeled Fraction (Fr.) 70%. The fraction was subjected to Sephadex LH-20 by mixtures of chloroform/methanol (1:1) yielding 16 fractions and marked Fr.70%-1 to Fr.70%-16. Then, Fr.70%-10 to Fr.70%-14 were purified by the elution of MeCN--H~2~O (70:30, (*v*/*v*), flow rate: 2 mL/min) through the semi-preparative HPLC (Waters, Parsippany, NJ, USA) using analytical and semi-preparative reverse-phase phenomenex biphenyl columns (5 μm, 250 × 4.6 mm and 5 μm, 250 × 10 mm in size), and finally afforded pure Compounds **1** (2.6 mg), **2** (12 mg), **3** (7 mg) and **4** (1 mg) at a retention time of 24.0 min, 25.0 min, 26.0 min and 27.4 min, respectively. The further ^1^H, ^13^C and 2D NMR spectral data were determined on a Bruker DRX 600 MHz NMR Spectrometers.

4,5-Dihydro-17-*O*-demethylgeldanamycin (**1**): yellow amorphous powder; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ +42.0° (*c* 0.18, CHCl~3~); UV (MeOH) λ~max~ 305 nm, HR-ESI-MS *m*/*z* 547.2636 \[M − H\]^−^ (calcs for C~28~H~40~N~2~O~9~ 547.2656); ^1^H and ^13^C NMR data, see [Table 4](#marinedrugs-15-00281-t004){ref-type="table"}.

3.5. Bioactive Assays {#sec3dot5-marinedrugs-15-00281}
---------------------

The tests of Compounds **1**--**4** against MRSA ATCC43300 were determined as previously described. The antifungal activities against three plant pathogens (*Setosphaeria turcica*, *Bipolaris maydis* and *Altemaria solani*) were conducted on BD Difco^TM^ Potato Dextrose Agar at 28 °C for 24 h. A series of two-fold dilution of tested samples was made with either LB broth or Potato Dextrose Broth in 24-well plates. The antibacterial tests were checked as the method described in the [Section 3.3](#sec3dot3-marinedrugs-15-00281){ref-type="sec"}. The antifungal tests were performed at 28 °C for 24 h, and inhibition of ≥95% of the growth was observed by stereo microscope.

The cytotoxic tests were measured by using the previous method. Compounds **1**--**4** were prepared as 50 mg/mL in DMSO, and a series of two-fold dilution was made with the assayed media. After 48 h of incubation, the cytotoxicities were assayed by the CCK method.

4. Conclusions {#sec4-marinedrugs-15-00281}
==============

This study firstly explored biological and chemical diversity of bacteria associated with the marine flatworm *Paraplanocera* sp. A total of 141 strains of bacteria were isolated including 45 strains of actinomycetes and 96 strains of other bacteria. Among them, there were three novel strains, suggesting that a rich biodiversity of bacteria may be associated with marine flatworms. The isolation and identification results of these bacteria indicated biological diversity and novelty of bacteria derived from this marine flatworm. One new GM analog (**1**) and three known GMs (**2**--**4**) were obtained from *Streptomyces* sp. XY-FW47. GM (**3**) showed potent bioactivity against HeLa cells with EC~50~ 1.12 μg/mL and against plant fungal pathogen *Setosphaeria turcica* with MIC 2.40 μg/mL. Preliminary discussion of SAR suggested that the existence of C-17 methoxy group and C-4,5 double bond might increase the bioactivities of GMs. Our study has provided new insights into the bacteria associated with marine flatworms.
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![Ultra-performance liquid chromatography--mass spectrometry (UPLC-MS) analysis and ultraviolet (UV) spectra of the crude extract of XY-FW120. The main metabolite produced by XY-FW120 is actinomycin D.](marinedrugs-15-00281-g004){#marinedrugs-15-00281-f004}

![UPLC-MS analysis and UV spectra of the crude extract of XY-FW47: (1) compounds with HR-ESI-MS \[M − H\]^−^ 547.2805, 533.2992 and 547.2636 in red are very likely novel GMs (highlighted by red color); and (2) compounds with HR-ESI-MS \[M − H\]^−^ 545.2548, 559.2783 and 561.2936 in black show to be known 17-*O*-demethylgeldanamycin, GM and 4,5-dihydrogeldanamycin (highlighted by black color).](marinedrugs-15-00281-g005){#marinedrugs-15-00281-f005}
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###### 

The diversity of the culturable bacteria derived from the marine flatworm *Paraplanocera* sp. A total of 141 strains of bacteria, including 37 species of actinobacteria and 64 species of non-actinobacteria, were identified by comparison 16S rDNA sequences of the isolates with their reference strains in the GeneBank of NCBI. All the known isolates have high identity percentage values with 98.5--100% except the three new species (*Pseudovibrio hongkongenesis* UST20140214-015B \[[@B15-marinedrugs-15-00281]\], *Pseudovibrio stylochi* UST20140214-052 \[[@B16-marinedrugs-15-00281]\], and *Deinococcus planocerae* XY-FW106 \[[@B17-marinedrugs-15-00281]\]).

                                             Species                 Isolate ID        Accession Number of the Most Similar Strain                    Species                   Isolate ID        Accession Number of the Most Similar Strain
  ------------------------------------------ ----------------------- ----------------- -------------------------------------------------------------- ------------------------- ----------------- ---------------------------------------------
  Actinobacteria                             *Streptomyces libani*   XY-FW38           JN180219                                                       *Mycobacterium pallens*   XY-FW60           KF378757
  *S. rutgersensis*                          XY-FW46                 FJ99174           *M. parafortuitum*                                             XY-FW63                   NZ_MVID01000062   
  *S. samsunensis*                           XY-FW47                 MF664376          *M. peregrinum*                                                XY-FW64                   AF537362          
  *S. sudanensis*                            XY-FW121                EF515876          *M. kumamotonense*                                             XY-FW71                   AB239925          
  *S. tendae*                                XY-FW57W                D63873            *M. poriferae*                                                 XY-FW80                   JN627174          
  *S. luridus*                               XY-FW100W               AB184150          *M. chubuense*                                                 XY-FW83                   JYNX01000034      
  *S. alboflavus*                            XY-FW107                JNXT01000131      *M. bacteremicum*                                              XY-FW90                   FJ172308          
  *S. cirratus*                              XY-FW109                AY999794          *M. iranicum*                                                  XY-FW62                   HQ009482          
  *S. parvulus*                              XY-FW120                AB184326          XY-FW77                                                        HQ009482                                    
  *S. bacillaris*                            XY-FW137                AB184439          *Microbacterium saperdae*                                      XY-FW102                  AB004719          
  *S. cavourensis*                           XY-FW153                AB184264                                                                                                                     
  *S. daliensis*                             XY-FW154                AY785161          *M. resistens*                                                 XY-FW145                  BCRA01000173      
  *S. phytohabitans*                         XY-FW134                JQ345722          *Tsukamurella tyrosinosolvens*                                 XY-FW86                   FJ643549          
  XY-FW142                                   JQ345722                                                                                                                                             
  *Micromonospora eburnea*                   XY-FW94                 AB107231          *T. strandjordii*                                              XY-FW101                  AF283283          
  *M. schwarzwaldensis*                      XY-FW95                 KC517406          *Brevibacterium iodinum*                                       XY-FW82                   X76567            
  *M. carbonacea*                            XY-FW99                 KM370042          *Micrococcus yunnanensis*                                      XY-FW48A                  FJ214355          
  *M. tulbaghiae*                            XY-FW123                EU196562          XY-FW75                                                        FJ214355                                    
  *M. echinospora*                           XY-FW130                KY818670          *Arthrobacter soli*                                            XY-FW120A                 EF660748          
  *M. marina*                                XY-FW132                KM370074          *Pseudonocardia carboxydivorans*                               XY-FW148                  EF114314          
  *M. wenchangensis*                         XY-FW65                 JQ768361                                                                                                                     
  *M. aurantiaca*                            XY-FW69                 CP002162          XY-FW149                                                       EF114314                                    
                                             XY-FW97                 CP002162                                                                                                                     
                                             XY-FW122                CP002162                                                                                                                     
  Non-actinobacteria                         *Bacillus lehensis*     XY-FW24           KX082867                                                       *M. variabilis*           XY-FW48B          KP640585
  *B. pumilus*                               XY-FW37                 AF492815                                                                         XY-FW54                   KP640585          
  *B. qibsonii*                              XY-FW43                 KM036072          *Ruegeria arenilitoris*                                        XY-FW31                   JQ807219          
  *B. aerius*                                XY-FW50                 KY243945                                                                         XY-FW32                   JQ807219          
  *B. berkeleyi*                             XY-FW53                 KR476448                                                                         XY-FW40                   JQ807219          
  *B. algicola*                              XY-FW55                 KY580789                                                                         XY-FW45                   JQ807219          
  *B. altitudinis*                           XY-FW66                 ASJC01000029                                                                     XY-FW58                   JQ807219          
  *B. amyloliquefaciens* subsp. *plntruim*   XY-FW105                FN597644                                                                         XY-FW72                   JQ807219          
                                                                                                                                                      XY-FW96                   JQ807219          
  *B. aerophilus*                            XY-FW112                KX951942                                                                         XY-FW138                  JQ807219          
  *B. flecus*                                XY-FW125                NZ_JANV01000041   ***Pseudovibrio hongkongenesis***                              UST20140214-015B          KP207599          
  *B. invictus*                              XY-FW131                KF060662          \[[@B15-marinedrugs-15-00281]\]                                                                            
  *B. megaterium*                            XY-FW1A                 MF597792          ***P. stylochi*** \[[@B16-marinedrugs-15-00281]\]              UST20140214-052           KP207600          
  *B. aquimaris*                             XY-FW5                  MF429570          *P. ascidiaceicola*                                            XY-FW21B                  LN812993          
                                             XY-FW23                 KY777466                                                                         XY-FW51                   LN812993          
                                             XY-FW49                 KY753251                                                                         XY-FW57                   LN812993          
  *B. marisflavi*                            XY-FW30                 MF062965          *Fictibacillus barbaricus*                                     XY-FW78                   KY436215          
                                             XY-F W59                MF062965          *F. phosphorivorans*                                           XY-FW42                   KY471632          
  *B. aryabhattai*                           XY-FW110                EF114313          *Photobacterium swingsii*                                      XY-FW3                    KY229808          
                                             XY-FW117                EF114313          *Arcobacter nitrofigilis*                                      XY-FW17                   EU106662          
  *B. nealsonii*                             XY-FW116                EU656111          *Staphylococcus epidermidis*                                   XY-FW21A                  MF429388          
                                             XY-FW126                EU656111          *Aquimarina mueller*                                           XY-FW21C                  AY608408          
                                             XY-FW133                EU656111          *Tenacibaculum aiptasiae*                                      XY-FW28                   KC178948          
                                             XY-FW139                EU656111          *Roseovarius aestuarii*                                        XY-FW56                   EU156066          
  *B. idriensis*                             XY-FW113                AY904033          *Cupriavidus campinensis*                                      XY-FW67                   KY010351          
                                             XY-FW115                AY904033          *Oceanobacillus picturae*                                      XY-FW73                   KX068643          
                                             XY-FW118                AY904033          ***Deinococcus planocerae*** \[[@B17-marinedrugs-15-00281]\]   XY-FW106                  KT886059          
                                             XY-FW129                AY904033          *Pseudomonas libanensis*                                       XY-FW111                  KY933473          
                                             XY-FW136                AY904033          *Paenibacillus cineris*                                        XY-FW114                  AJ575658          
  *Vibrio cyclitrophicus*                    XY-FW7B                 KY382786          *Stenotrophomonas rhizophila*                                  XY-FW119                  CP007597          
  *V. chagasii*                              XY-FW19                 LN832958          *Paracoccus honmiensis*                                        XY-FW124                  DQ342239          
  *H. locisalis*                             XY-FW34A                JQ799098          *Alcaligenes aquatilis* subsp. *phenolicus*                    XY-FW141                  JX986974          
  *H. halophilus*                            XY-FW34B                KX507262                                                                         XY-FW146                  AUBT01000026      
  *H. trueperi*                              XY-FW68                 LT635432                                                                                                                     
  *H. alkaliphilus*                          XY-FW10                 NZ_FOOG01000089                                                                                                              
                                             XY-FW16                 NZ_FOOG01000089                                                                                                              
  *Microbulbifer elongates*                  XY-FW27                 KY176867                                                                                                                     
  *M. epialgicus*                            XY-FW39                 KT758460                                                                                                                     
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###### 

The antibacterial activity against methicillin-resistant *Staphylococcus aureus* ATCC43300 (MRSA ATCC43300) of the bacteria associated with *Paraplanocera* sp.

  Bacteria Associated with *Paraplanocera* sp.   Tested Pathogen                
  ---------------------------------------------- ------------------------------ -----
  XY-FW47                                        *Streptomyces samsunensis*     +++
  XY-FW142                                       *Streptomyces phytohabitans*   +++
  XY-FW153                                       *Streptomyces cavourensis*     +++
  XY-FW120                                       *Streptomyces parvulus*        +++
  XY-FW120A                                      *Arthrobacter soli*            ++
  XY-FW105                                       *Bacillus siamensis*           ++
  XY-FW56                                        *Roseovarius aestuarii*        \+
  XY-FW48A                                       *Micrococcus yunnanensis*      \+

Final sample concentration: 100 μg/mL; + represents weak activity (0.2 \< OD ≤ 0.4); ++ represents moderate activity (0.1 \< OD ≤ 0.2); +++ represents high activity (0.05 \< OD ≤ 0.1); Negative control with DMSO (OD ≈ 0.8); Positive control with vancomycin (OD ≈ 0.05).
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###### 

The cytotoxic activity of the bacteria associated with *Paraplanocera* sp.

  Bacteria Associated with *Paraplanocera* sp.   Cell Line                      
  ---------------------------------------------- ------------------------------ -----
  XY-FW47                                        *Streptomyces samsunensis*     +++
  XY-FW120                                       *Streptomyces parvulus*        +++
  XY-FW142                                       *Streptomyces phytohabitans*   ++
  XY-FW153                                       *Streptomyces cavourensis*     ++
  XY-FW124                                       *Paracoccus honmiensis*        ++
  XY-FW105                                       *Bacillus siamensis*           \+
  XY-FW100W                                      *Streptomyces luridus*         \+

Final sample concentration: 100 μg/mL; + represents weak activity (0.2 \< OD ≤ 0.4); ++ represents moderate activity (0.1 \< OD ≤ 0.2); +++ represents high activity (0.05 \< OD ≤ 0.1); Negative control with DMSO (OD ≈ 0.8).
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###### 

^1^H and ^13^C NMR data for Compound **1** in CDCl~3~.

  Position   *δ*~C~        *δ*~H~ (*J* in Hz)             Position      *δ*~C~        *δ*~H~ (*J* in Hz)
  ---------- ------------- ------------------------------ ------------- ------------- --------------------
  1          168.3, C                                     16            117.2, C      
  2          133.1, C                                     17            152.8, C      
  3          138.4, CH     6.25, t (6.7)                  18            183.0, C      
  4          24.4, CH~2~   2.42, m                        19            107.4, CH     7.28, s
  5          29.6, CH~2~   1.77, m                        20            140.8, C      
  6          80.9, CH      3.37, m                        21            184.3, C      
  7          80.3, CH      5.18, d (4.2)                  NH                          8.99, s
  8          131.0, C                                     22-CH~3~      12.3, CH~3~   1.91, s
  9          133.8, CH     5.68, d (9.6)                  23-OCH~3~     59.0, CH~3~   3.41, s
  10         32.5, C       2.77, m                        24-OCONH~2~   156.1, C      
  11         73.3, CH      3.58, d (7.8)                  25-CH~3~      12.5, CH~3~   1.68, s
  12         82.5, CH      3.38, m                        26-CH~3~      12.7, CH~3~   0.96, d (7.5)
  13         34.9, CH~2~   1.73, m                        27-OCH~3~     57, CH~3~     3.35, s
  14         28.3, CH      1.75, m                        28-CH~3~      22.6, CH~3~   0.98, d (7.5)
  15         32.0, CH~2~   2.40, m 2.48, dd (13.2, 3.2)                               

[^1]: These authors contributed equally to this work.
